×

Biotech dips mid-year, then you buy: Pro

5:31 PM ET Wed, 31 Dec 2014

Biotech finished 2014 up 44 percent. David Seaburg, thinks biotech will outperform the S&P 500 this year, but there could be some suffering mid-year.